New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway (618 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 0223-5234linking), 2017 Jun 19; 138: 115-127.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 4.816, 5-year impact factor: 4.527
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021112048&doi=10.1016%2fj.ejmech.2017.06.013&partnerID=40&md5=15356de06fe5ca17cb43c0cd9034dd3f
Keywords: Anticancer Agents, Cyclodextrin, Gold Complexes, Proteasome Inhibitors, 2 Hydroxypropyl Beta Cyclodextrin, Alpha Cyclodextrin, Antineoplastic Agent, Coordination Compound, Dithiocarbamic Acid Derivative, Gold Derivative, Gold Iii Dithiocarbamate Complex, Methyl Beta Cyclodextrin, Oligosaccharide, Ubiquitin, Unclassified Drug, Water, Animal Experiment, Antineoplastic Activity, Aqueous Solution, Area Under The Curve, Article, Atomic Absorption Spectrometry, Blood Sampling, Distribution Half-Life, Drug Clearance, Drug Degradation, Drug Distribution, Drug Half Life, Drug Mechanism, Drug Solubility, Drug Stability, Drug Structure, Drug Synthesis, Elimination Rate Constant, Female, Human, Human Cell, Hydrophobicity, In Vitro Study, Mouse, Nonhuman, Tumor Cell Line, Ubiquitination, Antagonists And Inhibitors, Bagg Albino Mouse, Cell Proliferation, Chemical Structure, Chemistry, Dose Response, Drug Effects, Drug Screening, Metabolism, Structure Activity Relation, Tissue Distribution, Tumor Cell Culture, Dose-Response Relationship, Drug Screening Assays, Antitumor, Inbred Balb C, Molecular Structure, Proteasome Endopeptidase Complex, Structure-Activity Relationship,
Affiliations:
*** IBB - CNR ***
IBB-CNR, Istituto di Biostrutture e Bioimmagini, Sede Secondaria di Catania, Via Paolo Gaifami, 18 - 95126, Catania, Italy., Universita degli Studi di Padova, Dipartimento di Scienze Chimiche, Via F. Marzolo 1, 35131, Padova, Italy., Universita degli Studi di Padova, Dipartimento di Scienze Farmaceutiche, Via F. Marzolo 5, 35131, Padova, Italy., IBB-CNR, Istituto di Biostrutture e Bioimmagini, Sede Secondaria di Catania, Via Paolo Gaifami, 18 - 95126, Catania, Italy. Electronic address: giuseppe.pappalardo@cnr.it., Universita degli Studi di Padova, Dipartimento di Scienze Chimiche, Via F. Marzolo 1, 35131, Padova, Italy. Electronic address: dolores.fregona@unipd.it.,
Università degli Studi di Padova, Dipartimento di Scienze Chimiche, Via F. Marzolo 1, Padova, 35131, Italy
References:
Kelland, L., The resurgence of platinum-based cancer chemotherapy (2007) Nat. Rev. Cancer, 7, pp. 573-58
Florea, A.M., Büsselberg, D., Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects (2011) Cancers, 3, pp. 1351-1371
Oberoi, H.S., Nukolova, N.V., Kabanov, A.V., Bronich, T.K., Nanocarriers for delivery of platinum anticancer drugs (2013) Adv. Drug Deliv. Rev., 65, pp. 1667-1685
Nardon, C., Boscutti, G., Fregona, D., Beyond platinums: gold complexes as anticancer agents (2014) Anticancer Res., 34, pp. 487-492
Nardon, C., Fregona, D., Gold(III) complexes in the oncological preclinical arena: from aminoderivatives to peptidomimetics (2016) Curr. Top. Med. Chem., 16, pp. 360-380
Ronconi, L., Marzano, C., Zanello, P., Corsini, M., Miolo, G., Maccà, C., Trevisan, A., Fregona, D., Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties (2006) J. Med. Chem., 49, pp. 1648-1657
Ringhieri, P., Iannitti, R., Nardon, C., Palumbo, R., Fregona, D., Morelli, G., Accardo, A., Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes (2014) Int. J. Pharm., 473, pp. 194-202
Crini, G., A history of cyclodextrins (2014) Chem. Rev., 114, pp. 10940-10975
Hu, Q.D., Tang, G.P., Chu, P.K., Cyclodextrin-based host-guest supramolecular nanoparticles for delivery: from design to applications (2014) Acc. Chem. Res., 47, pp. 2017-2025
Ol'khovich, M.V., Sharapova, A.V., Lavrenov, S.N., Blokhina, S.V., Perlovich, G.L., Inclusion complexes of hydroxypropyl-β-cyclodextrin with novel cytotoxic compounds: solubility and thermodynamic properties (2014) Fluid Phase Equilib., 384, pp. 68-72
Jadhav, V.B., Jun, Y.J., Song, J.H., Park, M.K., Oh, J.H., Chae, S.W., Kim, I.S., Sohn, Y.S., A novel micelle-encapsulated platinum(II) anticancer agent (2010) J. Control. Release, 147, pp. 144-150
Avaji, P.J., Joo, H.I., Park, J.H., Park, K.S., Junc, Y.J., Lee, H.J., Sohn, Y.S., Synthesis and properties of a new micellar polyphosphazene–platinum(II) conjugate drug (2014) J. Inorg. Biochem., 140, pp. 45-52
Watanabe, T., Monzen, H., Hara, M., Mizowaki, T., Hiraoka, M., Pharmacokinetic model of myocardial (99m)Tc-sestamibi washout (2013) Ann. Nucl. Med., 27, pp. 279-284
Li, Y., Guo, P., Lin, N., Li, Q., Pharmacokinetics of di-phenyl-di-(2,4-dichlorbenzohydroxamato) tin (IV): a new metal-based candidate with promising antitumor activity in rats (2014) Inorg. Chim. Acta, 423, pp. 235-241
Wu, Y., Ding, L., Huang, N.Y., Wen, A.D., Liu, B., Li, W.B., Pharmacokinetics of metronidazole, tetracycline and bismuth in healthy volunteers after oral administration of compound tablets containing a combination of metronidazole, tetracycline hydrochloride and bismuth oxide (2015) Drug Res., 65, pp. 74-78
Ott, I., Biodistribution of metals and metallodrugs (2013) Comprehensive Inorganic Chemistry II: from Elements to Applications, 3, pp. 933-949. , second ed. J. Reedijk K. Poeppelmeier Elsevier Amsterdam
Vértiz, G., García-Ortuño, L.E., Bernal, J.P., Bravo-Gómez, M.E., Lounejeva, E., Huerta, A., Ruiz-Azuara, L., Pharmacokinetics and hematotoxicity of a novel copper-based anticancer agent: casiopeina III-Ea, after a single intravenous dose in rats (2014) Fundam. Clin. Pharmacol., 28, pp. 78-87
Sessa, C., Capri, G., Gianni, L., Peccatori, F., Grasselli, G., Bauer, J., Zucchetti, M., Marsoni, S., Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex (2000) Ann. Oncol., 11, pp. 977-983
Gottlieb, N.L., Comparative pharmacokinetics of parenteral and oral gold compounds (1982) J. Rheumatol., 8, pp. 99-109
Blocka, K., Furst, D.E., Landaw, E., Dromgoole, S., Blomberg, A., Paulus, H.E., Single dose pharmacokinetics of auranofin in rheumatoid arthritis (1982) J. Rheumatol., 8, pp. 110-119
Grigoreva, T.A., Tribulovich, V.G., Garabadzhiu, A.V., Melino, G., Barlev, N.A., The 26S proteasome is a multifaceted target for anti-cancer therapies (2015) Oncotarget, 6, pp. 24733-24749
Johnson, D.E., The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors (2015) Endocr.-Relat. cancer, 22, pp. T1-T17
Dalla Via, L., Nardon, C., Fregona, D., Targeting the ubiquitin–proteasome pathway with inorganic compounds to fight cancer: a challenge for the future (2012) Future Med. Chem., 4, pp. 525-543
Kisselev, A.F., Van Der Linden, W.A., Overkleeft, H.S., Proteasome inhibitors: an expanding army attacking a unique target (2012) Chem. Biol., 19, pp. 99-115
McBride, A., Klaus, J.O., Stockerl-Goldstein, K., Carfilzomib: a second-generation proteasome inhibitor for the treatment of multiple myeloma (2015) Am. J. Health Syst. Pharm., 72, pp. 353-360
Santoro, A.M., Lo Giudice, M.C., D'Urso, A., Lauceri, R., Purrello, R., Milardi, D., Cationic porphyrins are reversible proteasome inhibitors (2012) J. Am. Chem. Soc., 134, pp. 10451-10457
Santoro, A.M., Cunsolo, A., D'Urso, A., Sbardella, D., Tundo, G.R., Ciaccio, C., Coletta, M., Purrello, R., Cationic porphyrins are tunable gatekeepers of the 20S proteasome (2016) Chem. Sci., 7, pp. 1286-1297
Borissenko, L., Groll, M., 20S proteasome and its inhibitors: crystallographic knowledge for drug development (2007) Chem. Rev., 107, pp. 687-717
Deshaies, R.J., Protein degradation: prime time for PROTACs (2015) Nat. Chem. Biol., 11, pp. 634-635
Ciechanover, A., Proteolysis: from the lysosome to ubiquitin and the proteasome (2015) Nat. Rev. Mol. Cell. Biol., 16, pp. 322-324
Hou, Y.C., Deng, J.Y., Role of E3 ubiquitin ligases in gastric cancer (2015) World J. Gastroenterol., 21, pp. 786-793
An, H., Statsyuk, A.V., An inhibitor of ubiquitin conjugation and aggresome formation (2015) Chem. Sci., 6, pp. 5235-5245
Yang, Y., Kitagaki, J., Dai, R.M., Tsai, Y.C., Lorick, K.L., Ludwig, R.L., Pierre, S.A., Weissman, A.M., Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics (2007) Cancer Res., 67, pp. 9472-9481
Wei Xu, G., Ali, M., Wood, T.E., Wong, D., Maclean, N., Wang, X., Gronda, M., Schimmer, A.D., The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma (2010) Blood, 115, pp. 2251-2259
Zhang, X., Frezza, M., Milacic, V., Ronconi, L., Fan, Y., Bi, C., Fregona, D., Dou, Q.P., Inhibition of tumor proteasome activity by gold dithiocarbamato complexes via both redox-dependent and –independent processes (2010) J. Cell. Biochem., 109, pp. 162-172
Milacic, V., Chen, D., Ronconi, L., Landis-Piwowar, K.R., Fregona, D., Dou, Q.P., A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts (2006) Cancer Res., 66, pp. 10478-10486
Nardon, C., Schmitt, S.M., Yang, H., Zuo, J., Fregona, D., Dou, Q.P., Gold(III)-Dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia (2014) PLoS One, 9, p. e84248
Dantuma, N.P., Lindsten, K., Glas, R., Jelne, M., Masucci, M.G., Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells (2000) Nat. Biotecnol., 18, pp. 538-543
Rickardson, L., Wickstrom, M., Larsson, R., Lovborg, H., Image-based screening for the identification of novel proteasome inhibitors (2007) J. Biomol. Screen, 12, pp. 203-210
Momose, I., Tatsuda, D., Ohba, S., Masuda, T., Ikedaq, D., Nomoto, A., In vivo imaging of proteasome inhibition using a proteasome-sensitive fluorescent reporter (2012) Cancer Sci., 103, pp. 1730-1736
Urru, S.A.M., Veglianese, P., De Luigi, A., Fumagalli, E., Erba, E., Gonella-Diaza, R., Carrà, A., Salmona, M., A new fluorogenic peptide determines proteasome activity in single cells (2010) J. Med. Chem., 53, pp. 7452-7460
Arena, G., Fattorusso, R., Grasso, G., Grasso, G.I., Isernia, C., Malgieri, G., Milardi, D., Rizzarelli, E., Zinc(II) complexes of ubiquitin: speciation, affinity and binding features (2011) Chem. Eur. J., 17, pp. 11596-11603
Milardi, D., Arnesano, F., Grasso, G., Magrì, A., Tabbì, G., Scintilla, S., Natile, G., Rizzarelli, E., Ubiquitin stability and the Lys63-linked polyubiquitination site are compromised on copper binding (2007) Angew. Chem. Int. Ed., 46, pp. 7993-7995
Ronconi, L., Giovagnini, L., Marzano, C., Bettìo, F., Graziani, R., Pilloni, G., Fregona, D., Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity (2005) Inorg. Chem., 44, pp. 1867-1881
Mosmann, T.J., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays (1983) J. Immunol. Methods, 65, pp. 55-63
Grasso, G., Lanza, V., Malgieri, G., Fattorusso, R., Pietropaolo, A., Rizzarelli, E., Milardi, D., The insulin degrading enzyme activates ubiquitin and promotes the formation of K48 and K63 diubiquitin (2015) Chem. Comm., 51, pp. 15724-15727
Chen, J.J., Tsu, C.A., Gavin, J.M., Milhollen, M.A., Bruzzese, F.J., Mallender, W.D., Sintchak, M.D., Dick, L.R., Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues (2011) J. Biol. Chem., 286, pp. 40687-40877
Arena, G., Bellia, F., Frasca, G., Grasso, G., Lanza, V., Rizzarelli, E., Tabbì, G., Milardi, D., Inorganic stressors of ubiquitin (2013) Inorg. Chem., 52, pp. 9567-9573
Yanes, O., Aviles, F.X., Roepstorff, P., Jørgensen, T.J.D., Exploring the “intensity fading” phenomenon in the study of noncovalent interactions by MALDI-TOF mass spectrometry (2007) J. Am. Soc. Mass Spectrom., 18, pp. 359-367
Ronconi, L., Nardon, C., Boscutti, G., Fregona, D., Perspective gold(III)-dithiocarbamato anticancer therapeutics: learning from the past, moving to the future (2013) Advances in Anti-cancer Agents in Medicinal Chemistry, 2, pp. 130-172. , M. Prudhomme Bentham e-book
(2016) European Medicines Agency: EMA/CHMP/333892/2013-Background Review for Cyclodextrins Used as Excipients, , April
Irie, T., Uekama, K., Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation (1997) J. Pharm. Sci., 86, pp. 147-162
Gould, S., Scott, R.C., 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review (2005) Food Chem. Toxicol., 43, pp. 1451-1459
Stella, V.J., Quanren, H., Cyclodextrins (2008) Toxicol. Pathol., 36, pp. 30-42
Martin Del Valle, E.M., Cyclodextrins and their uses: a review (2004) Process Biochem., 39, pp. 1033-1046
Higuchi, T., Connors, K.A., Solid dispersion incorporated microcapsules: predictive tools for improve the half -life and dissolution rate of pioglitazone hydrochloride (1965) Adv. Anal. Chem. Instrum., 4, pp. 117-212
Challa, R., Ahuja, A., Ali, J., Khar, R.K., Cyclodextrins in drug delivery: an updated review (2005) AAPS Pharm. Sci. Tech., 6, pp. E329-E357
Trollope, L., Cruickshank, D.L., Noonan, T., Bourne, S.A., Sorrenti, M., Catenacci, L., Caira, M.R., Inclusion of trans-resveratrol in methylated cyclodextrins: synthesis and solid-state structures (2014) Beilstein J. Org. Chem., 10, pp. 3136-3151
Hiremath, S.N., Raghavendra, R.K., Sunil, F., Danki, L.S., Rampure, M.V., Swamy, P.V., Bhosale, U.V., Dissolution enhancement of gliclazide by preparation of inclusion complexes with β-cyclodextrin (2008) Asia J. Pharm., 2, pp. 73-76
Bertholet, P., Gueders, M., Dive, G., Albert, A., Barillaro, V., Perly, B., Cataldo, D., Evrard, B., The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solution (2005) J. Pharm. Pharm. Sci., 8, pp. 164-175
F.C Shaw, C., III, Gold-based therapeutic agents (1999) Chem. Rev., 99, pp. 2589-2600
Messori, L., Marcon, G., Gold complexes in the treatment of rheumatoid arthritis (2004) Marcel Dekker Metal Ions in Biological Systems, 41, pp. 279-304. , A. Sigel H. Sigel New York
Furst, D.E., Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis (1983) Pharmacother, 3, pp. 284-298
Blocka, K.L., Auranofin versus injectable gold. Comparison of pharmacokinetic properties (1983) Am. J. Med., 75, pp. 114-122
Walz, D.T., Di Martino, M.J., Griswold, D.E., Intoccia, A.P., Flanagan, T.L., Biologic actions and pharmacokinetic studies of auranofin (1983) Am. J. Med., 75, pp. 90-108
Smith, M.D., Brooks, P.M., Gold compounds in rheumatic diseases. II (1984) Med. J. Aust., 144, pp. 77-81
Walz, D.T., Griswold, D.E., Di Martino, M.J., Bumbier, E.E., Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats (1980) J. Rheumatol., 7, pp. 820-824
Blocka, K.L., Paulus, H.E., Furst, D.E., Clinical pharmacokinetics of oral and injectable gold compounds (1986) Clin. Pharmacokinet., 11, pp. 133-143
Rubinstein, H.M., Dietz, A.A., Serum gold. II. Levels in rheumatoid arthritis (1973) Ann. Rheum. Dis., 32, pp. 128-132
Gerber, R.C., Paulus, H.E., Jennrich, R.I., Lederer, M., Bluestone, R., Blahd, W.H., Pearson, C.M., Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter (1974) J. Lab. Clin. Med., 83, pp. 778-789
Waller, E.S., Massarella, J.W., Crout, J.E., Yakatan, G.J., The half-life of gold sodium thiomalate (1979) Arthritis Rheum., 22, pp. 1418-1419
Furst, D.E., Dromgoole, S.H., Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST) (1984) Clin. Rheumatol., 3, pp. 17-24
Hershko, A., The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture) (2005) Angew. Chem. Int. Ed., 117, pp. 6082-6094
Kulathu, Y., Komander, D., A typical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages (2012) Nat. Rev. Mol. Cell. Biol., 13, pp. 508-522
Clague, M.J., Urbè, S., Ubiquitin: same molecule, different degradation pathways (2010) Cell, 143, pp. 682-685
Trempe, J.F., Reading the ubiquitin postal code (2011) Curr. Opin. Struct. Biol., 21, pp. 792-801
Mani, A., Gelmann, E.P., The ubiquitin-proteasome pathway and its role in cancer (2005) J. Clin. Oncol., 23, pp. 4776-4789
Varadan, R., Walker, O., Pickart, C., Fushman, D., Structural properties of polyubiquitin chains in solution (2002) J. Mol. Biol., 324, pp. 637-647
Twerenbold, D., Gerber, D., Gritti, D., Gonin, Y., Netuschill, A., Rossel, F., Vuilleumier, J.L., Single molecule detector for mass spectrometry with mass independent detection efficiency (2001) Proteomics, 1, pp. 66-69
Karas, M., Bahr, U., Laser desorption ionization mass spectrometry of large biomolecules (1990) TrAC Trends Anal. Chem., 9, pp. 321-325
Hillenkamp, F., Karas, M., Beavis, R.C., Chait, B.T., Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers (1991) Anal. Chem., 63, pp. 1193A-1203A
Yanes, O., Villanueva, J., Querol, E., Aviles, F.X., Detection of non-covalent protein interactions by ‘intensity fading’ MALDI-TOF mass spectrometry: applications to proteases and protease inhibitors (2007) Nat. Protoc., 2, pp. 119-130
Schulman, B.A., Harper, J.W., Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways (2009) Nat. Rev. Mol. Cell Biol., 10, pp. 319-331
Spreckelmeyer, S., Orvig, C., Casini, A., Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin (2014) Molecules, 19, pp. 15584-15610
Altaf, M., Monim-Ul-Mehboob, M., Kawde, A.-N., Corona, G., Larcher, R., Ogasawara, M., Casagrande, N., Isab, A.A., New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status (2017) Oncotarget, 8, pp. 490-505
Barry, N.P.E., Sadler, P.J., 100 years of metal coordination chemistry: from Alfred Werner to anticancer metallodrugs (2014) Pure Appl. Chem., 86, pp. 1897-1910
Takahashi, K., Griem, P., Goebel, C., Gonzalez, J., Gleichmann, E., The antirheumatic drug gold, a coin with two faces: Au(I) and Au(III). Desired and undesired effects on the immune system (1994) Met. Based Drugs, 1, pp. 483-496
Shaw, G.F., III, Schraa, S., Gleichmann, E., Grover, Y.P., Dunemann, L., Jagarlamudi, A., Redox chemistry and [Au(CN)2] in the formation of gold metabolites (1994) Met. Based Drugs, 1, pp. 351-362
Buac, D., Schmitt, S., Ventro, G., Rani Kona, F., Ping Dou, Q., Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells (2012) Mini-Rev. Med. Chem., 12, pp. 1193-1201
Cvek, B., Dvorak, Z., The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor? (2008) Drug Discov. Today, 13, pp. 716-722
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 0223-5234linking), 2017 Jun 19; 138: 115-127.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 4.816, 5-year impact factor: 4.527
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021112048&doi=10.1016%2fj.ejmech.2017.06.013&partnerID=40&md5=15356de06fe5ca17cb43c0cd9034dd3f
Keywords: Anticancer Agents, Cyclodextrin, Gold Complexes, Proteasome Inhibitors, 2 Hydroxypropyl Beta Cyclodextrin, Alpha Cyclodextrin, Antineoplastic Agent, Coordination Compound, Dithiocarbamic Acid Derivative, Gold Derivative, Gold Iii Dithiocarbamate Complex, Methyl Beta Cyclodextrin, Oligosaccharide, Ubiquitin, Unclassified Drug, Water, Animal Experiment, Antineoplastic Activity, Aqueous Solution, Area Under The Curve, Article, Atomic Absorption Spectrometry, Blood Sampling, Distribution Half-Life, Drug Clearance, Drug Degradation, Drug Distribution, Drug Half Life, Drug Mechanism, Drug Solubility, Drug Stability, Drug Structure, Drug Synthesis, Elimination Rate Constant, Female, Human, Human Cell, Hydrophobicity, In Vitro Study, Mouse, Nonhuman, Tumor Cell Line, Ubiquitination, Antagonists And Inhibitors, Bagg Albino Mouse, Cell Proliferation, Chemical Structure, Chemistry, Dose Response, Drug Effects, Drug Screening, Metabolism, Structure Activity Relation, Tissue Distribution, Tumor Cell Culture, Dose-Response Relationship, Drug Screening Assays, Antitumor, Inbred Balb C, Molecular Structure, Proteasome Endopeptidase Complex, Structure-Activity Relationship,
Affiliations:
*** IBB - CNR ***
IBB-CNR, Istituto di Biostrutture e Bioimmagini, Sede Secondaria di Catania, Via Paolo Gaifami, 18 - 95126, Catania, Italy., Universita degli Studi di Padova, Dipartimento di Scienze Chimiche, Via F. Marzolo 1, 35131, Padova, Italy., Universita degli Studi di Padova, Dipartimento di Scienze Farmaceutiche, Via F. Marzolo 5, 35131, Padova, Italy., IBB-CNR, Istituto di Biostrutture e Bioimmagini, Sede Secondaria di Catania, Via Paolo Gaifami, 18 - 95126, Catania, Italy. Electronic address: giuseppe.pappalardo@cnr.it., Universita degli Studi di Padova, Dipartimento di Scienze Chimiche, Via F. Marzolo 1, 35131, Padova, Italy. Electronic address: dolores.fregona@unipd.it.,
Università degli Studi di Padova, Dipartimento di Scienze Chimiche, Via F. Marzolo 1, Padova, 35131, Italy
References:
Kelland, L., The resurgence of platinum-based cancer chemotherapy (2007) Nat. Rev. Cancer, 7, pp. 573-58
Florea, A.M., Büsselberg, D., Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects (2011) Cancers, 3, pp. 1351-1371
Oberoi, H.S., Nukolova, N.V., Kabanov, A.V., Bronich, T.K., Nanocarriers for delivery of platinum anticancer drugs (2013) Adv. Drug Deliv. Rev., 65, pp. 1667-1685
Nardon, C., Boscutti, G., Fregona, D., Beyond platinums: gold complexes as anticancer agents (2014) Anticancer Res., 34, pp. 487-492
Nardon, C., Fregona, D., Gold(III) complexes in the oncological preclinical arena: from aminoderivatives to peptidomimetics (2016) Curr. Top. Med. Chem., 16, pp. 360-380
Ronconi, L., Marzano, C., Zanello, P., Corsini, M., Miolo, G., Maccà, C., Trevisan, A., Fregona, D., Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties (2006) J. Med. Chem., 49, pp. 1648-1657
Ringhieri, P., Iannitti, R., Nardon, C., Palumbo, R., Fregona, D., Morelli, G., Accardo, A., Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes (2014) Int. J. Pharm., 473, pp. 194-202
Crini, G., A history of cyclodextrins (2014) Chem. Rev., 114, pp. 10940-10975
Hu, Q.D., Tang, G.P., Chu, P.K., Cyclodextrin-based host-guest supramolecular nanoparticles for delivery: from design to applications (2014) Acc. Chem. Res., 47, pp. 2017-2025
Ol'khovich, M.V., Sharapova, A.V., Lavrenov, S.N., Blokhina, S.V., Perlovich, G.L., Inclusion complexes of hydroxypropyl-β-cyclodextrin with novel cytotoxic compounds: solubility and thermodynamic properties (2014) Fluid Phase Equilib., 384, pp. 68-72
Jadhav, V.B., Jun, Y.J., Song, J.H., Park, M.K., Oh, J.H., Chae, S.W., Kim, I.S., Sohn, Y.S., A novel micelle-encapsulated platinum(II) anticancer agent (2010) J. Control. Release, 147, pp. 144-150
Avaji, P.J., Joo, H.I., Park, J.H., Park, K.S., Junc, Y.J., Lee, H.J., Sohn, Y.S., Synthesis and properties of a new micellar polyphosphazene–platinum(II) conjugate drug (2014) J. Inorg. Biochem., 140, pp. 45-52
Watanabe, T., Monzen, H., Hara, M., Mizowaki, T., Hiraoka, M., Pharmacokinetic model of myocardial (99m)Tc-sestamibi washout (2013) Ann. Nucl. Med., 27, pp. 279-284
Li, Y., Guo, P., Lin, N., Li, Q., Pharmacokinetics of di-phenyl-di-(2,4-dichlorbenzohydroxamato) tin (IV): a new metal-based candidate with promising antitumor activity in rats (2014) Inorg. Chim. Acta, 423, pp. 235-241
Wu, Y., Ding, L., Huang, N.Y., Wen, A.D., Liu, B., Li, W.B., Pharmacokinetics of metronidazole, tetracycline and bismuth in healthy volunteers after oral administration of compound tablets containing a combination of metronidazole, tetracycline hydrochloride and bismuth oxide (2015) Drug Res., 65, pp. 74-78
Ott, I., Biodistribution of metals and metallodrugs (2013) Comprehensive Inorganic Chemistry II: from Elements to Applications, 3, pp. 933-949. , second ed. J. Reedijk K. Poeppelmeier Elsevier Amsterdam
Vértiz, G., García-Ortuño, L.E., Bernal, J.P., Bravo-Gómez, M.E., Lounejeva, E., Huerta, A., Ruiz-Azuara, L., Pharmacokinetics and hematotoxicity of a novel copper-based anticancer agent: casiopeina III-Ea, after a single intravenous dose in rats (2014) Fundam. Clin. Pharmacol., 28, pp. 78-87
Sessa, C., Capri, G., Gianni, L., Peccatori, F., Grasselli, G., Bauer, J., Zucchetti, M., Marsoni, S., Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex (2000) Ann. Oncol., 11, pp. 977-983
Gottlieb, N.L., Comparative pharmacokinetics of parenteral and oral gold compounds (1982) J. Rheumatol., 8, pp. 99-109
Blocka, K., Furst, D.E., Landaw, E., Dromgoole, S., Blomberg, A., Paulus, H.E., Single dose pharmacokinetics of auranofin in rheumatoid arthritis (1982) J. Rheumatol., 8, pp. 110-119
Grigoreva, T.A., Tribulovich, V.G., Garabadzhiu, A.V., Melino, G., Barlev, N.A., The 26S proteasome is a multifaceted target for anti-cancer therapies (2015) Oncotarget, 6, pp. 24733-24749
Johnson, D.E., The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors (2015) Endocr.-Relat. cancer, 22, pp. T1-T17
Dalla Via, L., Nardon, C., Fregona, D., Targeting the ubiquitin–proteasome pathway with inorganic compounds to fight cancer: a challenge for the future (2012) Future Med. Chem., 4, pp. 525-543
Kisselev, A.F., Van Der Linden, W.A., Overkleeft, H.S., Proteasome inhibitors: an expanding army attacking a unique target (2012) Chem. Biol., 19, pp. 99-115
McBride, A., Klaus, J.O., Stockerl-Goldstein, K., Carfilzomib: a second-generation proteasome inhibitor for the treatment of multiple myeloma (2015) Am. J. Health Syst. Pharm., 72, pp. 353-360
Santoro, A.M., Lo Giudice, M.C., D'Urso, A., Lauceri, R., Purrello, R., Milardi, D., Cationic porphyrins are reversible proteasome inhibitors (2012) J. Am. Chem. Soc., 134, pp. 10451-10457
Santoro, A.M., Cunsolo, A., D'Urso, A., Sbardella, D., Tundo, G.R., Ciaccio, C., Coletta, M., Purrello, R., Cationic porphyrins are tunable gatekeepers of the 20S proteasome (2016) Chem. Sci., 7, pp. 1286-1297
Borissenko, L., Groll, M., 20S proteasome and its inhibitors: crystallographic knowledge for drug development (2007) Chem. Rev., 107, pp. 687-717
Deshaies, R.J., Protein degradation: prime time for PROTACs (2015) Nat. Chem. Biol., 11, pp. 634-635
Ciechanover, A., Proteolysis: from the lysosome to ubiquitin and the proteasome (2015) Nat. Rev. Mol. Cell. Biol., 16, pp. 322-324
Hou, Y.C., Deng, J.Y., Role of E3 ubiquitin ligases in gastric cancer (2015) World J. Gastroenterol., 21, pp. 786-793
An, H., Statsyuk, A.V., An inhibitor of ubiquitin conjugation and aggresome formation (2015) Chem. Sci., 6, pp. 5235-5245
Yang, Y., Kitagaki, J., Dai, R.M., Tsai, Y.C., Lorick, K.L., Ludwig, R.L., Pierre, S.A., Weissman, A.M., Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics (2007) Cancer Res., 67, pp. 9472-9481
Wei Xu, G., Ali, M., Wood, T.E., Wong, D., Maclean, N., Wang, X., Gronda, M., Schimmer, A.D., The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma (2010) Blood, 115, pp. 2251-2259
Zhang, X., Frezza, M., Milacic, V., Ronconi, L., Fan, Y., Bi, C., Fregona, D., Dou, Q.P., Inhibition of tumor proteasome activity by gold dithiocarbamato complexes via both redox-dependent and –independent processes (2010) J. Cell. Biochem., 109, pp. 162-172
Milacic, V., Chen, D., Ronconi, L., Landis-Piwowar, K.R., Fregona, D., Dou, Q.P., A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts (2006) Cancer Res., 66, pp. 10478-10486
Nardon, C., Schmitt, S.M., Yang, H., Zuo, J., Fregona, D., Dou, Q.P., Gold(III)-Dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia (2014) PLoS One, 9, p. e84248
Dantuma, N.P., Lindsten, K., Glas, R., Jelne, M., Masucci, M.G., Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells (2000) Nat. Biotecnol., 18, pp. 538-543
Rickardson, L., Wickstrom, M., Larsson, R., Lovborg, H., Image-based screening for the identification of novel proteasome inhibitors (2007) J. Biomol. Screen, 12, pp. 203-210
Momose, I., Tatsuda, D., Ohba, S., Masuda, T., Ikedaq, D., Nomoto, A., In vivo imaging of proteasome inhibition using a proteasome-sensitive fluorescent reporter (2012) Cancer Sci., 103, pp. 1730-1736
Urru, S.A.M., Veglianese, P., De Luigi, A., Fumagalli, E., Erba, E., Gonella-Diaza, R., Carrà, A., Salmona, M., A new fluorogenic peptide determines proteasome activity in single cells (2010) J. Med. Chem., 53, pp. 7452-7460
Arena, G., Fattorusso, R., Grasso, G., Grasso, G.I., Isernia, C., Malgieri, G., Milardi, D., Rizzarelli, E., Zinc(II) complexes of ubiquitin: speciation, affinity and binding features (2011) Chem. Eur. J., 17, pp. 11596-11603
Milardi, D., Arnesano, F., Grasso, G., Magrì, A., Tabbì, G., Scintilla, S., Natile, G., Rizzarelli, E., Ubiquitin stability and the Lys63-linked polyubiquitination site are compromised on copper binding (2007) Angew. Chem. Int. Ed., 46, pp. 7993-7995
Ronconi, L., Giovagnini, L., Marzano, C., Bettìo, F., Graziani, R., Pilloni, G., Fregona, D., Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity (2005) Inorg. Chem., 44, pp. 1867-1881
Mosmann, T.J., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays (1983) J. Immunol. Methods, 65, pp. 55-63
Grasso, G., Lanza, V., Malgieri, G., Fattorusso, R., Pietropaolo, A., Rizzarelli, E., Milardi, D., The insulin degrading enzyme activates ubiquitin and promotes the formation of K48 and K63 diubiquitin (2015) Chem. Comm., 51, pp. 15724-15727
Chen, J.J., Tsu, C.A., Gavin, J.M., Milhollen, M.A., Bruzzese, F.J., Mallender, W.D., Sintchak, M.D., Dick, L.R., Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues (2011) J. Biol. Chem., 286, pp. 40687-40877
Arena, G., Bellia, F., Frasca, G., Grasso, G., Lanza, V., Rizzarelli, E., Tabbì, G., Milardi, D., Inorganic stressors of ubiquitin (2013) Inorg. Chem., 52, pp. 9567-9573
Yanes, O., Aviles, F.X., Roepstorff, P., Jørgensen, T.J.D., Exploring the “intensity fading” phenomenon in the study of noncovalent interactions by MALDI-TOF mass spectrometry (2007) J. Am. Soc. Mass Spectrom., 18, pp. 359-367
Ronconi, L., Nardon, C., Boscutti, G., Fregona, D., Perspective gold(III)-dithiocarbamato anticancer therapeutics: learning from the past, moving to the future (2013) Advances in Anti-cancer Agents in Medicinal Chemistry, 2, pp. 130-172. , M. Prudhomme Bentham e-book
(2016) European Medicines Agency: EMA/CHMP/333892/2013-Background Review for Cyclodextrins Used as Excipients, , April
Irie, T., Uekama, K., Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation (1997) J. Pharm. Sci., 86, pp. 147-162
Gould, S., Scott, R.C., 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review (2005) Food Chem. Toxicol., 43, pp. 1451-1459
Stella, V.J., Quanren, H., Cyclodextrins (2008) Toxicol. Pathol., 36, pp. 30-42
Martin Del Valle, E.M., Cyclodextrins and their uses: a review (2004) Process Biochem., 39, pp. 1033-1046
Higuchi, T., Connors, K.A., Solid dispersion incorporated microcapsules: predictive tools for improve the half -life and dissolution rate of pioglitazone hydrochloride (1965) Adv. Anal. Chem. Instrum., 4, pp. 117-212
Challa, R., Ahuja, A., Ali, J., Khar, R.K., Cyclodextrins in drug delivery: an updated review (2005) AAPS Pharm. Sci. Tech., 6, pp. E329-E357
Trollope, L., Cruickshank, D.L., Noonan, T., Bourne, S.A., Sorrenti, M., Catenacci, L., Caira, M.R., Inclusion of trans-resveratrol in methylated cyclodextrins: synthesis and solid-state structures (2014) Beilstein J. Org. Chem., 10, pp. 3136-3151
Hiremath, S.N., Raghavendra, R.K., Sunil, F., Danki, L.S., Rampure, M.V., Swamy, P.V., Bhosale, U.V., Dissolution enhancement of gliclazide by preparation of inclusion complexes with β-cyclodextrin (2008) Asia J. Pharm., 2, pp. 73-76
Bertholet, P., Gueders, M., Dive, G., Albert, A., Barillaro, V., Perly, B., Cataldo, D., Evrard, B., The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solution (2005) J. Pharm. Pharm. Sci., 8, pp. 164-175
F.C Shaw, C., III, Gold-based therapeutic agents (1999) Chem. Rev., 99, pp. 2589-2600
Messori, L., Marcon, G., Gold complexes in the treatment of rheumatoid arthritis (2004) Marcel Dekker Metal Ions in Biological Systems, 41, pp. 279-304. , A. Sigel H. Sigel New York
Furst, D.E., Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis (1983) Pharmacother, 3, pp. 284-298
Blocka, K.L., Auranofin versus injectable gold. Comparison of pharmacokinetic properties (1983) Am. J. Med., 75, pp. 114-122
Walz, D.T., Di Martino, M.J., Griswold, D.E., Intoccia, A.P., Flanagan, T.L., Biologic actions and pharmacokinetic studies of auranofin (1983) Am. J. Med., 75, pp. 90-108
Smith, M.D., Brooks, P.M., Gold compounds in rheumatic diseases. II (1984) Med. J. Aust., 144, pp. 77-81
Walz, D.T., Griswold, D.E., Di Martino, M.J., Bumbier, E.E., Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats (1980) J. Rheumatol., 7, pp. 820-824
Blocka, K.L., Paulus, H.E., Furst, D.E., Clinical pharmacokinetics of oral and injectable gold compounds (1986) Clin. Pharmacokinet., 11, pp. 133-143
Rubinstein, H.M., Dietz, A.A., Serum gold. II. Levels in rheumatoid arthritis (1973) Ann. Rheum. Dis., 32, pp. 128-132
Gerber, R.C., Paulus, H.E., Jennrich, R.I., Lederer, M., Bluestone, R., Blahd, W.H., Pearson, C.M., Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter (1974) J. Lab. Clin. Med., 83, pp. 778-789
Waller, E.S., Massarella, J.W., Crout, J.E., Yakatan, G.J., The half-life of gold sodium thiomalate (1979) Arthritis Rheum., 22, pp. 1418-1419
Furst, D.E., Dromgoole, S.H., Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST) (1984) Clin. Rheumatol., 3, pp. 17-24
Hershko, A., The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture) (2005) Angew. Chem. Int. Ed., 117, pp. 6082-6094
Kulathu, Y., Komander, D., A typical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages (2012) Nat. Rev. Mol. Cell. Biol., 13, pp. 508-522
Clague, M.J., Urbè, S., Ubiquitin: same molecule, different degradation pathways (2010) Cell, 143, pp. 682-685
Trempe, J.F., Reading the ubiquitin postal code (2011) Curr. Opin. Struct. Biol., 21, pp. 792-801
Mani, A., Gelmann, E.P., The ubiquitin-proteasome pathway and its role in cancer (2005) J. Clin. Oncol., 23, pp. 4776-4789
Varadan, R., Walker, O., Pickart, C., Fushman, D., Structural properties of polyubiquitin chains in solution (2002) J. Mol. Biol., 324, pp. 637-647
Twerenbold, D., Gerber, D., Gritti, D., Gonin, Y., Netuschill, A., Rossel, F., Vuilleumier, J.L., Single molecule detector for mass spectrometry with mass independent detection efficiency (2001) Proteomics, 1, pp. 66-69
Karas, M., Bahr, U., Laser desorption ionization mass spectrometry of large biomolecules (1990) TrAC Trends Anal. Chem., 9, pp. 321-325
Hillenkamp, F., Karas, M., Beavis, R.C., Chait, B.T., Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers (1991) Anal. Chem., 63, pp. 1193A-1203A
Yanes, O., Villanueva, J., Querol, E., Aviles, F.X., Detection of non-covalent protein interactions by ‘intensity fading’ MALDI-TOF mass spectrometry: applications to proteases and protease inhibitors (2007) Nat. Protoc., 2, pp. 119-130
Schulman, B.A., Harper, J.W., Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways (2009) Nat. Rev. Mol. Cell Biol., 10, pp. 319-331
Spreckelmeyer, S., Orvig, C., Casini, A., Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin (2014) Molecules, 19, pp. 15584-15610
Altaf, M., Monim-Ul-Mehboob, M., Kawde, A.-N., Corona, G., Larcher, R., Ogasawara, M., Casagrande, N., Isab, A.A., New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status (2017) Oncotarget, 8, pp. 490-505
Barry, N.P.E., Sadler, P.J., 100 years of metal coordination chemistry: from Alfred Werner to anticancer metallodrugs (2014) Pure Appl. Chem., 86, pp. 1897-1910
Takahashi, K., Griem, P., Goebel, C., Gonzalez, J., Gleichmann, E., The antirheumatic drug gold, a coin with two faces: Au(I) and Au(III). Desired and undesired effects on the immune system (1994) Met. Based Drugs, 1, pp. 483-496
Shaw, G.F., III, Schraa, S., Gleichmann, E., Grover, Y.P., Dunemann, L., Jagarlamudi, A., Redox chemistry and [Au(CN)2] in the formation of gold metabolites (1994) Met. Based Drugs, 1, pp. 351-362
Buac, D., Schmitt, S., Ventro, G., Rani Kona, F., Ping Dou, Q., Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells (2012) Mini-Rev. Med. Chem., 12, pp. 1193-1201
Cvek, B., Dvorak, Z., The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor? (2008) Drug Discov. Today, 13, pp. 716-722
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway
The gold(III)-dithiocarbamate complex AuL12 (dibromo [ethyl-N-(dithiocarboxy-kS,kS′)-N-methylglycinate] gold(III)), is endowed with promising in vitro/in vivo antitumor activity and toxicological profile. Here, we report our recent strategies to improve its water solubility and stability under physiological conditions along with our efforts for unravelling its tangled mechanism of action. We used three types of α-cyclodextrins (CDs), namely β-CD, Me-β-CD and HP-β-CD to prepare aqueous solutions of AuL12. The ability of these natural oligosaccharide carriers to enhance water solubility of hydrophobic compounds, allowed drug stability of AuL12 to be investigated. Moreover, pharmacokinetic experiments were first carried out for a gold(III) coordination compound, after i.v. injection of the nanoformulation AuL12/HP-β-CD to female mice. The gold content in the blood samples was detected at scheduled times by AAS (atomic absorption spectrometry) analysis, highlighting a fast biodistribution with a tβ1/2 of few minutes and a slow escretion (tα1/2 of 14.3 h). The in vitro cytotoxic activity of AuL12 was compared with the AuL12/HP-β-CD mixture against a panel of three human tumor cell lines (i.e., HeLa, KB and MCF7). Concerning the mechanism of action, we previously reported the proteasome-inhibitory activity of some our gold(III)-based compounds. In this work, we moved from the proteasome target to upstream of the important ubiquitin-proteasome pathway, testing the effects of AuL12 on the polyubiquitination reactions involving the Ub–activating (E1) and –conjugating (E2) enzymes. © 2017 Elsevier Masson SAS
The gold(III)-dithiocarbamate complex AuL12 (dibromo [ethyl-N-(dithiocarboxy-kS,kS′)-N-methylglycinate] gold(III)), is endowed with promising in vitro/in vivo antitumor activity and toxicological profile. Here, we report our recent strategies to improve its water solubility and stability under physiological conditions along with our efforts for unravelling its tangled mechanism of action. We used three types of α-cyclodextrins (CDs), namely β-CD, Me-β-CD and HP-β-CD to prepare aqueous solutions of AuL12. The ability of these natural oligosaccharide carriers to enhance water solubility of hydrophobic compounds, allowed drug stability of AuL12 to be investigated. Moreover, pharmacokinetic experiments were first carried out for a gold(III) coordination compound, after i.v. injection of the nanoformulation AuL12/HP-β-CD to female mice. The gold content in the blood samples was detected at scheduled times by AAS (atomic absorption spectrometry) analysis, highlighting a fast biodistribution with a tβ1/2 of few minutes and a slow escretion (tα1/2 of 14.3 h). The in vitro cytotoxic activity of AuL12 was compared with the AuL12/HP-β-CD mixture against a panel of three human tumor cell lines (i.e., HeLa, KB and MCF7). Concerning the mechanism of action, we previously reported the proteasome-inhibitory activity of some our gold(III)-based compounds. In this work, we moved from the proteasome target to upstream of the important ubiquitin-proteasome pathway, testing the effects of AuL12 on the polyubiquitination reactions involving the Ub–activating (E1) and –conjugating (E2) enzymes. © 2017 Elsevier Masson SAS
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway
Other filter: ([btitle,keywords] "Anticancer Agents" O ...
Platella C, Capasso D, Riccardi C, Musumeci D, Dellagreca M, Montesarchio D
* Natural compounds from Juncus plants interacting with telomeric and oncogene G-quadruplex structures as potential anticancer agents (8 views)
Org Biomol Chem (ISSN: 1477-0520linking), 2021 Nov 8; N/D: N/D-N/D.
Impact Factor: 3.876
View Export to BibTeX Export to EndNote
Riccardi C, Napolitano E, Platella C, Musumeci D, Melone MAB, Montesarchio D
* Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics (10 views)
Med Res Rev (ISSN: 0198-6325linking, 1098-1128electronic), 2021 Jan; 41(1): 464-506.
Impact Factor: 9.3
View Export to BibTeX Export to EndNote
Ogloblina AM, Iaccarino N, Capasso D, Di Gaetano S, Garzarella EU, Dolinnaya NG, Yakubovskaya MG, Pagano B, Amato J, Randazzo A
* Toward G-Quadruplex-Based Anticancer Agents: Biophysical and Biological Studies of Novel AS1411 Derivatives (61 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2020 Oct 21; 21(20): N/D-N/D.
Impact Factor: 4.556
View Export to BibTeX Export to EndNote
Riccardi C, Musumeci D, Capuozzo A, Irace C, King S, Russo Krauss I, Paduano L, Montesarchio D
* "dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents (202 views)
Acs Biomater Sci Eng (ISSN: 2373-9878), 2018; 4(1): 163-174.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Oliveri V, Zimbone S, Giuffrida ML, Bellia F, Tomasello MF, Vecchio G
* Porphyrin Cyclodextrin Conjugates Modulate Amyloid Beta Peptide Aggregation and Cytotoxicity (489 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2018; 24(24): 6349-6353.
Impact Factor: 5.476
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Viale M, Maric I, Vecchio G
* Linear polymers of beta and gamma cyclodextrins with a polyglutamic acid backbone as carriers for doxorubicin (464 views)
Carbohyd Polym (ISSN: 0144-8617), 2017 Dec 1; 177: 355-360.
Impact Factor: 5.158
View Export to BibTeX Export to EndNote
Oliveri V, Lanza V, Milardi D, Viale M, Maric I, Sgarlata C, Vecchio G
* Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents (478 views)
Metallomics (ISSN: 1756-5901, 1756-591x), 2017 Oct 18; 9(10): 1439-1446.
Impact Factor: 4.069
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Vecchio G
* Cyclodextrin Nanoparticles Bearing 8-Hydroxyquinoline Ligands as Multifunctional Biomaterials (794 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2017; 23(18): 4442-4449.
Impact Factor: 5.16
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Vecchio G
* Structural Isomers of Cyclodextrin-Bearing IOX1 Compound as Inhibitors of Aβ Aggregation (340 views)
Chemistryselect (ISSN: 2365-6549), 2017; 2(2): 655-659.
Impact Factor: 1.505
View Export to BibTeX Export to EndNote
Cucciolito ME, Trinchillo M, Iannitti R, Palumbo R, Tesauro D, Tuzi A, Ruffo F, D'Amora A
* Sugar-Incorporated N-Heterocyclic-Carbene-Containing Gold(I) Complexes: Synthesis, Characterization, and Cytotoxic Evaluation (328 views)
Eur J Inorg Chem (ISSN: 1434-1948, 1099-0682e), 2017; 2017(42): 4855-4961.
Impact Factor: 2.507
View Export to BibTeX Export to EndNote
Giglio V, Bellia F, Oliveri V, Vecchio G
* Aminocyclodextrin Oligomers as Protective Agents of Protein Aggregation (452 views)
Chempluschem, 2016; 81(7): 660-665.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Vecchio G
* Cyclodextrin 3-functionalized with 8-hydroxyquinoline as an antioxidant inhibitor of metal-induced amyloid aggregation (426 views)
Chempluschem (ISSN: 2192-6506), 2015; 80(4): 762-770.
Impact Factor: 2.836
View Export to BibTeX Export to EndNote
Caso JV, Russo L, Palmieri M, Malgieri G, Galdiero S, Falanga A, Isernia C, Iacovino R
* Investigating the inclusion properties of aromatic amino acids complexing beta-cyclodextrins in model peptides (418 views)
Amino Acids (ISSN: 0939-4451, 1438-2199, 1438-2199electronic), 2015; N/D: N/D-N/D.
Impact Factor: 3.196
View Export to BibTeX Export to EndNote
Rizzarelli E, Vecchio G, Puglisi A, La Mendola D, Pugliesi A
* New Conjugate Of Cyclodextrin Useful As Anti-Inflammatory And Anti-Tumoral Agents And For Preparation Of Medicaments With Colon Site-Specific Delivery (253 views)
Am J Obstet Gynecol (ISSN: 0002-9378), 2015; 212(3): 413-413.
Impact Factor: 4.681
View Export to BibTeX Export to EndNote
Ferraro G, Massai L, Messori L, Cinellu MA, Merlino A
* Structural evidences for a secondary gold binding site in the hydrophobic box of lysozyme (360 views)
Biometals (ISSN: 0966-0844), 2015; 28(4): 745-754.
Impact Factor: 2.134
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Pietropaolo A, Vecchio G
* Unusual Cyclodextrin Derivatives as a New Avenue to Modulate Self- and Metal-Induced Aβ Aggregation (684 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2015; 21(40): 14047-14059.
Impact Factor: 5.771
View Export to BibTeX Export to EndNote
Giuffrida A, Maccarrone G, Cucinotta V, Orlandini S, Contino A
* Recent advances in chiral separation of amino acids using capillary electromigration techniques (179 views)
J Chromatogr A (ISSN: 0021-9673, 0021-9673linking), 2014 Oct 10; 1363: 41-50.
Impact Factor: 4.169
View Export to BibTeX Export to EndNote
Ringhieri P, Iannitti R, Nardon C, Palumbo R, Fregona D, Morelli G, Accardo A
* Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes (559 views)
Int J Pharm (ISSN: 0378-5173, 1873-3476), 2014 Oct 1; 473(1-2): 194-202.
Impact Factor: 3.65
View Export to BibTeX Export to EndNote
Oliveri V, Attanasio F, Puglisi A, Spencer J, Sgarlata C, Vecchio G
* Multifunctional 8-hydroxyquinoline-appended cyclodextrins as new inhibitors of metal-induced protein aggregation (710 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2014 Jul 14; 20(29): 8954-8964.
Impact Factor: 5.731
View Export to BibTeX Export to EndNote
Orlandini S, Pasquini B, Gotti R, Giuffrida A, Paternostro F, Furlanetto S
* Analytical quality by design in the development of a cyclodextrin-modified capillary electrophoresis method for the assay of metformin and its related substances (216 views)
Electrophoresis (ISSN: 0173-0835), 2014; 35(17): 2538-2545.
Impact Factor: 3.028
View Export to BibTeX Export to EndNote
Magrì A, D'Alessandro F, Di Stefano DA, Campagna T, Pappalardo G, Impellizzeri G, La Mendola D
* Copper(ii) Coordination Properties Of The Integrin Ligand Sequence Phsrn And Its New Beta-Cyclodextrin Conjugates (497 views)
Journal Of Inorganic Biochemistry, 2012 Sep; 113: 15-24.
Impact Factor: 3.444
View Export to BibTeX Export to EndNote
Riccio A, Cubellis MV
* Gain of function in CDKN1C (510 views)
Nature Genetics (ISSN: 1061-4036), 2012 Jul; 44(7): 737-738.
Impact Factor: 35.209
View Export to BibTeX Export to EndNote
Santoro AM, Lo Giudice MC, D'Urso A, Lauceri R, Purrello R, Milardi D
* Cationic porphyrins are reversible proteasome inhibitors (447 views)
J Am Chem Soc (ISSN: 0002-7863, 0002-2786, 1520-5126), 2012 Jun 27; 134(25): 10451-10457.
Impact Factor: 10.677
View Export to BibTeX Export to EndNote
Gringeri CV, Menchise V, Rizzitelli S, Cittadino E, Catanzaro V, Dati G, Chaabane L, Digilio G, Aime S
* Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases (503 views)
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2012 Mar; 7(2): 175-184.
Impact Factor: 2.872
View Export to BibTeX Export to EndNote
Grasso GI, Bellia F, Arena G, Vecchio G, Rizzarelli E
* Noncovalent interaction-driven stereoselectivity of copper(II) complexes with cyclodextrin derivatives of L- and D-carnosine (1241 views)
Inorg Chem (ISSN: 1520-510x, 0020-1669, 1520-510xelectronic), 2011 Jun 6; 50(11): 4917-4924.
Impact Factor: 4.601
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, Grasso G, MacCarrone G, Mazzaglia A, Messina M, Vecchio G
* Diaminotrehalose-capped β-cyclodextrin, a new member of hemispherodextrins: Synthesis, thermodynamic and spectroscopic characterization and its exploitation in chiral electrokinetic chromatography (400 views)
J Sep Sci (ISSN: 1615-9306), 2011 Jan; 34(1): 70-76.
Impact Factor: 2.733
View Export to BibTeX Export to EndNote
Puglisi A, Rizzarelli E, Vecchio G, Iacovino R, Benedetti E, Pedone C, Saviano M
* Crystal And Molecular Structure Of Beta-Cyclodextrins Functionalized With The Anti-Inflammatory Drug Etodolac (420 views)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2009 Dec; 91(12): 1227-1235.
Impact Factor: 2.605
View Export to BibTeX Export to EndNote
Bellia F, La Mendola D, Pedone C, Rizzarelli E, Saviano M, Vecchio G
* Selectively functionalized cyclodextrins and their metal complexes (419 views)
Chem Soc Rev (ISSN: 1460-4744, 0306-0012, 1460-4744electronic), 2009 Sep; 38(9): 2756-2781.
Impact Factor: 20.086
View Export to BibTeX Export to EndNote
Bonomo RP, D'Alessandro F, Grasso G, Impellizzeri G, Pappalardo G, Rizzarelli E, Tabbì G
* Carcinine-beta-cyclodextrin derivatives as scavenger entities of (OH) radicals and SOD-like properties of their copper(II) complexes (284 views)
Inorg Chim Acta (ISSN: 0020-1693), 2008 May 5; 361(6): 1705-1714.
Impact Factor: 1.94
View Export to BibTeX Export to EndNote
Leese MP, Jourdan FL, Gaukroger K, Mahon MF, Newman SP, Foster PA, Stengel C, Regis-Lydi S, Ferrandis E, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BVL
* Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents (464 views)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2008 Mar 13; 51(5): 1295-1308.
Impact Factor: 4.898
View Export to BibTeX Export to EndNote
Bellia F, Amorini AM, La Mendola D, Vecchio G, Tavazzi B, Giardina B, Di Pietro V, Lazzarino G, Rizzarelli E
* New glycosidic derivatives of histidine-containing dipeptides with antioxidant properties and resistant to carnosinase activity (463 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2008 Feb; 43(2): 373-380.
Impact Factor: 2.882
View Export to BibTeX Export to EndNote
Amorini AM, Bellia F, Di Pietro V, Giardina B, La Mendola D, Lazzarino G, Sortino S, Tavazzi B, Rizzarelli E, Vecchio G
* Synthesis And Antioxidant Activity Of New Homocarnosine Beta-Cyclodextrin Conjugates (379 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2007 Jul; 42(7): 910-920.
Impact Factor: 2.301
View Export to BibTeX Export to EndNote
Bellia F, La Mendola D, Maccarrone G, Mineo P, Vitalini D, Scamporrino E, Sortino S, Vecchio G, Rizzarelli E
* Copper(II) Complexes With Beta-Cyclodextrin-Homocarnosine Conjugates And Their Antioxidant Activity (265 views)
Inorg Chim Acta (ISSN: 0020-1693), 2007 Feb 15; 360(3): 945-954.
Impact Factor: 1.713
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, Grasso G, Maccarrone G, Messina M, Vecchio G
* High selectivity in new chiral separations of dansyl amino acids by cyclodextrin derivatives in electrokinetic chromatography (290 views)
J Chromatogr A (ISSN: 0021-9673, 0021-9673linking), 2007; 1155(2): 172-179.
Impact Factor: 3.641
View Export to BibTeX Export to EndNote
Puglisi A, Purrello R, Rizzarelli E, Sortino S, Vecchio G
* Spectroscopic and self-association behavior of a porphyrin-β- cyclodextrin conjugate (376 views)
New J Chem (ISSN: 1144-0546), 2007; 31(8): 1499-1506.
Impact Factor: 2.651
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, Maccarrone G, Messina M, Puglisi A, Rizzarelli E, Vecchio G
* Coordination properties of 3-functionalized β-cyclodextrins. Thermodynamic stereoselectivity of copper(II) complexes of the A, B-diamino derivative and its exploitation in LECE (356 views)
Dalton T (ISSN: 1477-9226, 1477-9234, 1477-9234electronic), 2005 Sep 21; (16): 2731-2736.
Impact Factor: 3.003
View Export to BibTeX Export to EndNote
Impellizzeri G, D'Alessandro F, Pappalardo G, Tringali C
* Synthesis And Structural Characterisation Of Two Novel Diastereoisomeric Naproxen-Appended Beta-Cyclodextrin Derivatives (346 views)
J Incl Phenom (ISSN: 0923-0750), 2005; 51(3-4): 173-180.
Impact Factor: 1.02
View Export to BibTeX Export to EndNote
Puglisi A, Tabbì G, Vecchio G
* Bioconjugates of cyclodextrins of manganese salen-type ligand with superoxide dismutase activity (412 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2004 Jun; 98(6): 969-976.
Impact Factor: 2.225
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, La Mendola D, Maccarrone G, Puglisi A, Rizzarelli E, Vecchio G
* 3-Amino Derivative Of Beta-Cyclodextrin: Thermodynamics Of Copper (ii) Complexes And Exploitation Of Its Enantioselectivity In The Separation Of Amino Acid Racemates By Ligand Exchange Capillary Electrophoresis (350 views)
And Life Sciencesjournal Of Chromatography B Analytical Technologies In The Biomedical, 2004 Feb 5; 800(1-2): 127-133.
Impact Factor: 1.403
View Export to BibTeX Export to EndNote
Mineo P, Vitalini D, La Mendola D, Rizzarelli E, Scamporrino E, Vecchio G
* Coordination Features Of Difunctionalized Beta-Cyclodextrins With Carnosine: Esi-Ms And Spectroscopic Investigations On 6a, 6d-Di-(beta-Alanyl-L-Histidine)-6a, 6d-Dideoxy-Beta-Cyclodextrin And 6a, 6c-Di-(beta-Alanyl-L-Histidine)-6a, 6c-Dideoxy-Beta-Cyclodextrin And Their Copper (ii) Complexes (491 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2004 Feb; 98(2): 254-265.
Impact Factor: 2.225
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, Grasso G, Maccarrone G, Vecchio G
* Ligand exchange chiral separations by cyclodextrin derivatives in capillary electrophoresis (427 views)
Analyst (ISSN: 0003-2654), 2003; 128(2): 134-136.
Impact Factor: 2.251
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, Grasso G, Maccarrone G, Messina M
* The Simultaneous Separation Of Different Enantiomeric Pairs In Capillary Electrophoresis By Mixing Different Hemispherodextrins, A Very Versatile Class Of Receptors (258 views)
J Chromatogr A (ISSN: 0021-9673, 0021-9673linking), 2002 Dec 6; 979(1-2): 137-145.
Impact Factor: 3.098
View Export to BibTeX Export to EndNote
La Mendola D, Sortino S, Rizzarelli E, Vecchiog
* Synthesis Of New Carnosine Derivatives Of R-Cyclodextrin And Their Hydroxyl Radical Scavanger Ability (321 views)
Helvetica Chimica Acta, 2002; 85: 1633-1643.
Impact Factor: 1.394
View Export to BibTeX Export to EndNote
Vecchio G, La Mendola D, Rizzarelli E, Sortino S
* SOD-like activity of copper(II) complexes of beta-cyclodextrins functionalized with carnosine (290 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2001 Sep; 86(1): N/D-N/D.
Impact Factor: 1.729
View Export to BibTeX Export to EndNote
Impellizzeri G, Pappalardo G, D'Alessandro F, Rizzarelli E, Saviano M, Iacovino R, Benedetti E, Pedone C
Erratum: Solid state and solution conformation of 6-{4-[N-tert- butoxycarbonyl-N-(N'-ethyl)propanamide]imidazolyl}-6- deoxycyclomaltoheptaose: Evidence of self-inclusion of the boc group within the β-cyclodextrin cavity (European Journal of Organic Chemistry (2000) (1065-1076)) (448 views)
Eur J Org Chem (ISSN: 1434-193x), 2000; (12): 2345-2345.
Impact Factor: 2.15
View Export to BibTeX Export to EndNote
Impellizzeri G, Pappalardo G, D'Alessandro F, Rizzarelli E, Saviano M, Iacovino R, Benedetti E, Pedone C
Solid state and solution conformation of 6-{4-[N-tert-butoxycarbonyl-N- (N'-ethyl)propanamide]imidazolyl}-6-deoxycyclomaltoheptaose: Evidence of self-inclusion of the Boc group within the β-cyclodextrin cavity (360 views)
European J Org Chem (ISSN: 1434-193x), 2000; (6): 1065-1076.
Impact Factor: 2.15
View Export to BibTeX Export to EndNote
Campagna T, Grasso G, Rizzarelli E, Vecchio G
L- and D-cysteine derivatives of β-cyclodextrin: Different molecular recognition properties of their copper(II) complexes for amino acids (348 views)
Inorg Chim Acta (ISSN: 0020-1693), 1998; 275-276: 395-400.
Impact Factor: 1.454
View Export to BibTeX Export to EndNote
Bonomo RP, Cucinotta V, D'Alessandro F, Impellizzeri G, Maccarrone G, Rizzarelli E, Vecchio G, Carima L, Corradini R, Sartor G, Marchelli R
Chiral recognition by the copper(ii) complex of 6-deoxy-6-n-(2 - methylaminopyridine)-β-cyclodextrin (381 views)
Chirality (ISSN: 0899-0042), 1997; 9(4): 341-349.
Impact Factor: 1.915
View Export to BibTeX Export to EndNote
Bonomo RP, Pedotti S, Vecchio G, Rizzarelli E
Molecular Recognition of Amino Acids by Copper(II) Complexes of 6A, 6X-Diamino-6A, 6 X-dideoxy-β-cyclodextrin (X = B, C, D) (254 views)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 1996 Nov 6; 35(23): 6873-6877.
Impact Factor: 2.736
View Export to BibTeX Export to EndNote
Bonomo RP, Di Blasio B, Maccarrone G, Pavone V, Pedone C, Rizzarelli E, Saviano M, Vecchio G
Crystal and Molecular Structure of the [6-Deoxy-6-[(2-(4-imidazolyl)ethyl)amino]cyclomaltoheptaose]copper(II) Ternary Complex with L-Tryptophanate. Role of Weak Forces in the Chiral Recognition Process Assisted by a Metallocyclodextrin (314 views)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 1996 Jul 17; 35(15): 4497-4504.
Impact Factor: 2.736
View Export to BibTeX Export to EndNote
Di Blasio B, Galdiero S, Saviano M, Pedone C, Benedetti E, Rizzarelli E, Pedotti S, Vecchio G, Gibbons WA
Synthesis And Structural Characterization Of 6i, 6ii-Diamino-6i, 6ii-Dideoxy-Cyclomaltoheptaose, A Difunctionalized Beta-Cyclodextrin (426 views)
Carbohydr Res, 1996 Feb 28; 282(1): 41-52.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Cucinotta V, Grasso G, Pedotti S, Rizzarelli E, Vecchio G, Di Blasio B, Isernia C, Saviano M, Pedone C
A Platinum(II) Diamino-β-cyclodextrin Complex: A Crystallographic and Solution Study. Synthesis and Structural Characterization of a Platinum(II) Complex of 6A, 6B-Diamino-6A, 6B-dideoxycyclomaltoheptaose (594 views)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 1996; 35(26): 7535-7540.
Impact Factor: 2.736
View Export to BibTeX Export to EndNote
Di Blasio B, Galdiero S, Saviano M, De Simone G, Benedetti E, Pedone C, Gibbons WA, Deschenaux R, Rizzarelli E, Vecchio G
Functionalized cyclodextrins: Synthesis and structural characterization of 6-deoxy-6-{4-[N-tert-butoxycarbonyl-2-aminoethyl]-imidazolyl}-cyclomaltoheptaose (346 views)
Supramol Chem (ISSN: 1061-0278), 1996; 7(1): 47-54.
Impact Factor: 3.19
View Export to BibTeX Export to EndNote
Condorelli G, Costanzo LL, De Guidi G, Giuffrida S, Rizzarelli E, Vecchio G
INHIBITION OF PHOTOHEMOLYSIS BY COPPER(II) COMPLEXES WITH SOD-LIKE ACTIVITY (504 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 1994 Jun; 54(4): 257-265.
Impact Factor: 1.342
View Export to BibTeX Export to EndNote
DALESSANDRO F, GULINO F, IMPELLIZZERI G, PAPPALARDO G, RIZZARELLI E, SCIOTTO D, VECCHIO G
A new water soluble host compound possessing two different hydrophobic recognition cavities: Calix[4]arene derivative conjugated with monofunctionalized β-cyclodextrin (425 views)
Tetrahedron Lett (ISSN: 0040-4039), 1994 Jan 24; 35(4): 629-632.
Impact Factor: 2.5
View Export to BibTeX Export to EndNote
Cucinotta V, Mangano A, Nobile G, Santoro AM, Vecchio G
New platinum(II) complexes of β-cyclodextrin diamine derivatives and their antitumor activity (468 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 1993 Nov 15; 52(3): 183-190.
Impact Factor: 1.342
View Export to BibTeX Export to EndNote
Di Blasio B, Pavone V, Nastri F, Isernia C, Saviano M, Pedone C, Cucinotta V, Impellizzeri G, Rizzarelli E, Vecchio G
Conformation for a β-cyclodextrin monosubstituted with a cyclic dipeptide (500 views)
P Natl Acad Sci Usa (ISSN: 0027-8424, 1091-6490, 0027-8424print), 1992 Sep 1; 89(15): 7218-7221.
Impact Factor: 9.04
View Export to BibTeX Export to EndNote
Rossi F, Zaccaro L, Di Blasio B, Pavone V, Maglio O, Saviano M, Pedone C, Cucinotta V, Impellizzeri G, Rizzarelli E, Vecchio G
beta-Cyclodextrins as potent bioactive delivery system (435 views)
Peptides, 1992; N/D: 577-578.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Cucinotta V, D'Alessandro F, Impellizzeri G, Pappalardo G, Rizzarelli E, Vecchio G
Cyclopeptide Functionalized beta-Cyclodextrin. A New Class of Potentially Enzyme Mimicking Compound with Two Recognition Sites (268 views)
Chem Commun, 1991; N/D: 293-294.
Impact Factor: 0
View Export to BibTeX Export to EndNote
* Natural compounds from Juncus plants interacting with telomeric and oncogene G-quadruplex structures as potential anticancer agents (8 views)
Org Biomol Chem (ISSN: 1477-0520linking), 2021 Nov 8; N/D: N/D-N/D.
Impact Factor: 3.876
View Export to BibTeX Export to EndNote
Riccardi C, Napolitano E, Platella C, Musumeci D, Melone MAB, Montesarchio D
* Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics (10 views)
Med Res Rev (ISSN: 0198-6325linking, 1098-1128electronic), 2021 Jan; 41(1): 464-506.
Impact Factor: 9.3
View Export to BibTeX Export to EndNote
Ogloblina AM, Iaccarino N, Capasso D, Di Gaetano S, Garzarella EU, Dolinnaya NG, Yakubovskaya MG, Pagano B, Amato J, Randazzo A
* Toward G-Quadruplex-Based Anticancer Agents: Biophysical and Biological Studies of Novel AS1411 Derivatives (61 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2020 Oct 21; 21(20): N/D-N/D.
Impact Factor: 4.556
View Export to BibTeX Export to EndNote
Riccardi C, Musumeci D, Capuozzo A, Irace C, King S, Russo Krauss I, Paduano L, Montesarchio D
* "dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents (202 views)
Acs Biomater Sci Eng (ISSN: 2373-9878), 2018; 4(1): 163-174.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Oliveri V, Zimbone S, Giuffrida ML, Bellia F, Tomasello MF, Vecchio G
* Porphyrin Cyclodextrin Conjugates Modulate Amyloid Beta Peptide Aggregation and Cytotoxicity (489 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2018; 24(24): 6349-6353.
Impact Factor: 5.476
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Viale M, Maric I, Vecchio G
* Linear polymers of beta and gamma cyclodextrins with a polyglutamic acid backbone as carriers for doxorubicin (464 views)
Carbohyd Polym (ISSN: 0144-8617), 2017 Dec 1; 177: 355-360.
Impact Factor: 5.158
View Export to BibTeX Export to EndNote
Oliveri V, Lanza V, Milardi D, Viale M, Maric I, Sgarlata C, Vecchio G
* Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents (478 views)
Metallomics (ISSN: 1756-5901, 1756-591x), 2017 Oct 18; 9(10): 1439-1446.
Impact Factor: 4.069
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Vecchio G
* Cyclodextrin Nanoparticles Bearing 8-Hydroxyquinoline Ligands as Multifunctional Biomaterials (794 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2017; 23(18): 4442-4449.
Impact Factor: 5.16
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Vecchio G
* Structural Isomers of Cyclodextrin-Bearing IOX1 Compound as Inhibitors of Aβ Aggregation (340 views)
Chemistryselect (ISSN: 2365-6549), 2017; 2(2): 655-659.
Impact Factor: 1.505
View Export to BibTeX Export to EndNote
Cucciolito ME, Trinchillo M, Iannitti R, Palumbo R, Tesauro D, Tuzi A, Ruffo F, D'Amora A
* Sugar-Incorporated N-Heterocyclic-Carbene-Containing Gold(I) Complexes: Synthesis, Characterization, and Cytotoxic Evaluation (328 views)
Eur J Inorg Chem (ISSN: 1434-1948, 1099-0682e), 2017; 2017(42): 4855-4961.
Impact Factor: 2.507
View Export to BibTeX Export to EndNote
Giglio V, Bellia F, Oliveri V, Vecchio G
* Aminocyclodextrin Oligomers as Protective Agents of Protein Aggregation (452 views)
Chempluschem, 2016; 81(7): 660-665.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Vecchio G
* Cyclodextrin 3-functionalized with 8-hydroxyquinoline as an antioxidant inhibitor of metal-induced amyloid aggregation (426 views)
Chempluschem (ISSN: 2192-6506), 2015; 80(4): 762-770.
Impact Factor: 2.836
View Export to BibTeX Export to EndNote
Caso JV, Russo L, Palmieri M, Malgieri G, Galdiero S, Falanga A, Isernia C, Iacovino R
* Investigating the inclusion properties of aromatic amino acids complexing beta-cyclodextrins in model peptides (418 views)
Amino Acids (ISSN: 0939-4451, 1438-2199, 1438-2199electronic), 2015; N/D: N/D-N/D.
Impact Factor: 3.196
View Export to BibTeX Export to EndNote
Rizzarelli E, Vecchio G, Puglisi A, La Mendola D, Pugliesi A
* New Conjugate Of Cyclodextrin Useful As Anti-Inflammatory And Anti-Tumoral Agents And For Preparation Of Medicaments With Colon Site-Specific Delivery (253 views)
Am J Obstet Gynecol (ISSN: 0002-9378), 2015; 212(3): 413-413.
Impact Factor: 4.681
View Export to BibTeX Export to EndNote
Ferraro G, Massai L, Messori L, Cinellu MA, Merlino A
* Structural evidences for a secondary gold binding site in the hydrophobic box of lysozyme (360 views)
Biometals (ISSN: 0966-0844), 2015; 28(4): 745-754.
Impact Factor: 2.134
View Export to BibTeX Export to EndNote
Oliveri V, Bellia F, Pietropaolo A, Vecchio G
* Unusual Cyclodextrin Derivatives as a New Avenue to Modulate Self- and Metal-Induced Aβ Aggregation (684 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2015; 21(40): 14047-14059.
Impact Factor: 5.771
View Export to BibTeX Export to EndNote
Giuffrida A, Maccarrone G, Cucinotta V, Orlandini S, Contino A
* Recent advances in chiral separation of amino acids using capillary electromigration techniques (179 views)
J Chromatogr A (ISSN: 0021-9673, 0021-9673linking), 2014 Oct 10; 1363: 41-50.
Impact Factor: 4.169
View Export to BibTeX Export to EndNote
Ringhieri P, Iannitti R, Nardon C, Palumbo R, Fregona D, Morelli G, Accardo A
* Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes (559 views)
Int J Pharm (ISSN: 0378-5173, 1873-3476), 2014 Oct 1; 473(1-2): 194-202.
Impact Factor: 3.65
View Export to BibTeX Export to EndNote
Oliveri V, Attanasio F, Puglisi A, Spencer J, Sgarlata C, Vecchio G
* Multifunctional 8-hydroxyquinoline-appended cyclodextrins as new inhibitors of metal-induced protein aggregation (710 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2014 Jul 14; 20(29): 8954-8964.
Impact Factor: 5.731
View Export to BibTeX Export to EndNote
Orlandini S, Pasquini B, Gotti R, Giuffrida A, Paternostro F, Furlanetto S
* Analytical quality by design in the development of a cyclodextrin-modified capillary electrophoresis method for the assay of metformin and its related substances (216 views)
Electrophoresis (ISSN: 0173-0835), 2014; 35(17): 2538-2545.
Impact Factor: 3.028
View Export to BibTeX Export to EndNote
Magrì A, D'Alessandro F, Di Stefano DA, Campagna T, Pappalardo G, Impellizzeri G, La Mendola D
* Copper(ii) Coordination Properties Of The Integrin Ligand Sequence Phsrn And Its New Beta-Cyclodextrin Conjugates (497 views)
Journal Of Inorganic Biochemistry, 2012 Sep; 113: 15-24.
Impact Factor: 3.444
View Export to BibTeX Export to EndNote
Riccio A, Cubellis MV
* Gain of function in CDKN1C (510 views)
Nature Genetics (ISSN: 1061-4036), 2012 Jul; 44(7): 737-738.
Impact Factor: 35.209
View Export to BibTeX Export to EndNote
Santoro AM, Lo Giudice MC, D'Urso A, Lauceri R, Purrello R, Milardi D
* Cationic porphyrins are reversible proteasome inhibitors (447 views)
J Am Chem Soc (ISSN: 0002-7863, 0002-2786, 1520-5126), 2012 Jun 27; 134(25): 10451-10457.
Impact Factor: 10.677
View Export to BibTeX Export to EndNote
Gringeri CV, Menchise V, Rizzitelli S, Cittadino E, Catanzaro V, Dati G, Chaabane L, Digilio G, Aime S
* Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases (503 views)
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2012 Mar; 7(2): 175-184.
Impact Factor: 2.872
View Export to BibTeX Export to EndNote
Grasso GI, Bellia F, Arena G, Vecchio G, Rizzarelli E
* Noncovalent interaction-driven stereoselectivity of copper(II) complexes with cyclodextrin derivatives of L- and D-carnosine (1241 views)
Inorg Chem (ISSN: 1520-510x, 0020-1669, 1520-510xelectronic), 2011 Jun 6; 50(11): 4917-4924.
Impact Factor: 4.601
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, Grasso G, MacCarrone G, Mazzaglia A, Messina M, Vecchio G
* Diaminotrehalose-capped β-cyclodextrin, a new member of hemispherodextrins: Synthesis, thermodynamic and spectroscopic characterization and its exploitation in chiral electrokinetic chromatography (400 views)
J Sep Sci (ISSN: 1615-9306), 2011 Jan; 34(1): 70-76.
Impact Factor: 2.733
View Export to BibTeX Export to EndNote
Puglisi A, Rizzarelli E, Vecchio G, Iacovino R, Benedetti E, Pedone C, Saviano M
* Crystal And Molecular Structure Of Beta-Cyclodextrins Functionalized With The Anti-Inflammatory Drug Etodolac (420 views)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2009 Dec; 91(12): 1227-1235.
Impact Factor: 2.605
View Export to BibTeX Export to EndNote
Bellia F, La Mendola D, Pedone C, Rizzarelli E, Saviano M, Vecchio G
* Selectively functionalized cyclodextrins and their metal complexes (419 views)
Chem Soc Rev (ISSN: 1460-4744, 0306-0012, 1460-4744electronic), 2009 Sep; 38(9): 2756-2781.
Impact Factor: 20.086
View Export to BibTeX Export to EndNote
Bonomo RP, D'Alessandro F, Grasso G, Impellizzeri G, Pappalardo G, Rizzarelli E, Tabbì G
* Carcinine-beta-cyclodextrin derivatives as scavenger entities of (OH) radicals and SOD-like properties of their copper(II) complexes (284 views)
Inorg Chim Acta (ISSN: 0020-1693), 2008 May 5; 361(6): 1705-1714.
Impact Factor: 1.94
View Export to BibTeX Export to EndNote
Leese MP, Jourdan FL, Gaukroger K, Mahon MF, Newman SP, Foster PA, Stengel C, Regis-Lydi S, Ferrandis E, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BVL
* Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents (464 views)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2008 Mar 13; 51(5): 1295-1308.
Impact Factor: 4.898
View Export to BibTeX Export to EndNote
Bellia F, Amorini AM, La Mendola D, Vecchio G, Tavazzi B, Giardina B, Di Pietro V, Lazzarino G, Rizzarelli E
* New glycosidic derivatives of histidine-containing dipeptides with antioxidant properties and resistant to carnosinase activity (463 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2008 Feb; 43(2): 373-380.
Impact Factor: 2.882
View Export to BibTeX Export to EndNote
Amorini AM, Bellia F, Di Pietro V, Giardina B, La Mendola D, Lazzarino G, Sortino S, Tavazzi B, Rizzarelli E, Vecchio G
* Synthesis And Antioxidant Activity Of New Homocarnosine Beta-Cyclodextrin Conjugates (379 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2007 Jul; 42(7): 910-920.
Impact Factor: 2.301
View Export to BibTeX Export to EndNote
Bellia F, La Mendola D, Maccarrone G, Mineo P, Vitalini D, Scamporrino E, Sortino S, Vecchio G, Rizzarelli E
* Copper(II) Complexes With Beta-Cyclodextrin-Homocarnosine Conjugates And Their Antioxidant Activity (265 views)
Inorg Chim Acta (ISSN: 0020-1693), 2007 Feb 15; 360(3): 945-954.
Impact Factor: 1.713
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, Grasso G, Maccarrone G, Messina M, Vecchio G
* High selectivity in new chiral separations of dansyl amino acids by cyclodextrin derivatives in electrokinetic chromatography (290 views)
J Chromatogr A (ISSN: 0021-9673, 0021-9673linking), 2007; 1155(2): 172-179.
Impact Factor: 3.641
View Export to BibTeX Export to EndNote
Puglisi A, Purrello R, Rizzarelli E, Sortino S, Vecchio G
* Spectroscopic and self-association behavior of a porphyrin-β- cyclodextrin conjugate (376 views)
New J Chem (ISSN: 1144-0546), 2007; 31(8): 1499-1506.
Impact Factor: 2.651
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, Maccarrone G, Messina M, Puglisi A, Rizzarelli E, Vecchio G
* Coordination properties of 3-functionalized β-cyclodextrins. Thermodynamic stereoselectivity of copper(II) complexes of the A, B-diamino derivative and its exploitation in LECE (356 views)
Dalton T (ISSN: 1477-9226, 1477-9234, 1477-9234electronic), 2005 Sep 21; (16): 2731-2736.
Impact Factor: 3.003
View Export to BibTeX Export to EndNote
Impellizzeri G, D'Alessandro F, Pappalardo G, Tringali C
* Synthesis And Structural Characterisation Of Two Novel Diastereoisomeric Naproxen-Appended Beta-Cyclodextrin Derivatives (346 views)
J Incl Phenom (ISSN: 0923-0750), 2005; 51(3-4): 173-180.
Impact Factor: 1.02
View Export to BibTeX Export to EndNote
Puglisi A, Tabbì G, Vecchio G
* Bioconjugates of cyclodextrins of manganese salen-type ligand with superoxide dismutase activity (412 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2004 Jun; 98(6): 969-976.
Impact Factor: 2.225
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, La Mendola D, Maccarrone G, Puglisi A, Rizzarelli E, Vecchio G
* 3-Amino Derivative Of Beta-Cyclodextrin: Thermodynamics Of Copper (ii) Complexes And Exploitation Of Its Enantioselectivity In The Separation Of Amino Acid Racemates By Ligand Exchange Capillary Electrophoresis (350 views)
And Life Sciencesjournal Of Chromatography B Analytical Technologies In The Biomedical, 2004 Feb 5; 800(1-2): 127-133.
Impact Factor: 1.403
View Export to BibTeX Export to EndNote
Mineo P, Vitalini D, La Mendola D, Rizzarelli E, Scamporrino E, Vecchio G
* Coordination Features Of Difunctionalized Beta-Cyclodextrins With Carnosine: Esi-Ms And Spectroscopic Investigations On 6a, 6d-Di-(beta-Alanyl-L-Histidine)-6a, 6d-Dideoxy-Beta-Cyclodextrin And 6a, 6c-Di-(beta-Alanyl-L-Histidine)-6a, 6c-Dideoxy-Beta-Cyclodextrin And Their Copper (ii) Complexes (491 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2004 Feb; 98(2): 254-265.
Impact Factor: 2.225
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, Grasso G, Maccarrone G, Vecchio G
* Ligand exchange chiral separations by cyclodextrin derivatives in capillary electrophoresis (427 views)
Analyst (ISSN: 0003-2654), 2003; 128(2): 134-136.
Impact Factor: 2.251
View Export to BibTeX Export to EndNote
Cucinotta V, Giuffrida A, Grasso G, Maccarrone G, Messina M
* The Simultaneous Separation Of Different Enantiomeric Pairs In Capillary Electrophoresis By Mixing Different Hemispherodextrins, A Very Versatile Class Of Receptors (258 views)
J Chromatogr A (ISSN: 0021-9673, 0021-9673linking), 2002 Dec 6; 979(1-2): 137-145.
Impact Factor: 3.098
View Export to BibTeX Export to EndNote
La Mendola D, Sortino S, Rizzarelli E, Vecchiog
* Synthesis Of New Carnosine Derivatives Of R-Cyclodextrin And Their Hydroxyl Radical Scavanger Ability (321 views)
Helvetica Chimica Acta, 2002; 85: 1633-1643.
Impact Factor: 1.394
View Export to BibTeX Export to EndNote
Vecchio G, La Mendola D, Rizzarelli E, Sortino S
* SOD-like activity of copper(II) complexes of beta-cyclodextrins functionalized with carnosine (290 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2001 Sep; 86(1): N/D-N/D.
Impact Factor: 1.729
View Export to BibTeX Export to EndNote
Impellizzeri G, Pappalardo G, D'Alessandro F, Rizzarelli E, Saviano M, Iacovino R, Benedetti E, Pedone C
Erratum: Solid state and solution conformation of 6-{4-[N-tert- butoxycarbonyl-N-(N'-ethyl)propanamide]imidazolyl}-6- deoxycyclomaltoheptaose: Evidence of self-inclusion of the boc group within the β-cyclodextrin cavity (European Journal of Organic Chemistry (2000) (1065-1076)) (448 views)
Eur J Org Chem (ISSN: 1434-193x), 2000; (12): 2345-2345.
Impact Factor: 2.15
View Export to BibTeX Export to EndNote
Impellizzeri G, Pappalardo G, D'Alessandro F, Rizzarelli E, Saviano M, Iacovino R, Benedetti E, Pedone C
Solid state and solution conformation of 6-{4-[N-tert-butoxycarbonyl-N- (N'-ethyl)propanamide]imidazolyl}-6-deoxycyclomaltoheptaose: Evidence of self-inclusion of the Boc group within the β-cyclodextrin cavity (360 views)
European J Org Chem (ISSN: 1434-193x), 2000; (6): 1065-1076.
Impact Factor: 2.15
View Export to BibTeX Export to EndNote
Campagna T, Grasso G, Rizzarelli E, Vecchio G
L- and D-cysteine derivatives of β-cyclodextrin: Different molecular recognition properties of their copper(II) complexes for amino acids (348 views)
Inorg Chim Acta (ISSN: 0020-1693), 1998; 275-276: 395-400.
Impact Factor: 1.454
View Export to BibTeX Export to EndNote
Bonomo RP, Cucinotta V, D'Alessandro F, Impellizzeri G, Maccarrone G, Rizzarelli E, Vecchio G, Carima L, Corradini R, Sartor G, Marchelli R
Chiral recognition by the copper(ii) complex of 6-deoxy-6-n-(2 - methylaminopyridine)-β-cyclodextrin (381 views)
Chirality (ISSN: 0899-0042), 1997; 9(4): 341-349.
Impact Factor: 1.915
View Export to BibTeX Export to EndNote
Bonomo RP, Pedotti S, Vecchio G, Rizzarelli E
Molecular Recognition of Amino Acids by Copper(II) Complexes of 6A, 6X-Diamino-6A, 6 X-dideoxy-β-cyclodextrin (X = B, C, D) (254 views)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 1996 Nov 6; 35(23): 6873-6877.
Impact Factor: 2.736
View Export to BibTeX Export to EndNote
Bonomo RP, Di Blasio B, Maccarrone G, Pavone V, Pedone C, Rizzarelli E, Saviano M, Vecchio G
Crystal and Molecular Structure of the [6-Deoxy-6-[(2-(4-imidazolyl)ethyl)amino]cyclomaltoheptaose]copper(II) Ternary Complex with L-Tryptophanate. Role of Weak Forces in the Chiral Recognition Process Assisted by a Metallocyclodextrin (314 views)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 1996 Jul 17; 35(15): 4497-4504.
Impact Factor: 2.736
View Export to BibTeX Export to EndNote
Di Blasio B, Galdiero S, Saviano M, Pedone C, Benedetti E, Rizzarelli E, Pedotti S, Vecchio G, Gibbons WA
Synthesis And Structural Characterization Of 6i, 6ii-Diamino-6i, 6ii-Dideoxy-Cyclomaltoheptaose, A Difunctionalized Beta-Cyclodextrin (426 views)
Carbohydr Res, 1996 Feb 28; 282(1): 41-52.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Cucinotta V, Grasso G, Pedotti S, Rizzarelli E, Vecchio G, Di Blasio B, Isernia C, Saviano M, Pedone C
A Platinum(II) Diamino-β-cyclodextrin Complex: A Crystallographic and Solution Study. Synthesis and Structural Characterization of a Platinum(II) Complex of 6A, 6B-Diamino-6A, 6B-dideoxycyclomaltoheptaose (594 views)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 1996; 35(26): 7535-7540.
Impact Factor: 2.736
View Export to BibTeX Export to EndNote
Di Blasio B, Galdiero S, Saviano M, De Simone G, Benedetti E, Pedone C, Gibbons WA, Deschenaux R, Rizzarelli E, Vecchio G
Functionalized cyclodextrins: Synthesis and structural characterization of 6-deoxy-6-{4-[N-tert-butoxycarbonyl-2-aminoethyl]-imidazolyl}-cyclomaltoheptaose (346 views)
Supramol Chem (ISSN: 1061-0278), 1996; 7(1): 47-54.
Impact Factor: 3.19
View Export to BibTeX Export to EndNote
Condorelli G, Costanzo LL, De Guidi G, Giuffrida S, Rizzarelli E, Vecchio G
INHIBITION OF PHOTOHEMOLYSIS BY COPPER(II) COMPLEXES WITH SOD-LIKE ACTIVITY (504 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 1994 Jun; 54(4): 257-265.
Impact Factor: 1.342
View Export to BibTeX Export to EndNote
DALESSANDRO F, GULINO F, IMPELLIZZERI G, PAPPALARDO G, RIZZARELLI E, SCIOTTO D, VECCHIO G
A new water soluble host compound possessing two different hydrophobic recognition cavities: Calix[4]arene derivative conjugated with monofunctionalized β-cyclodextrin (425 views)
Tetrahedron Lett (ISSN: 0040-4039), 1994 Jan 24; 35(4): 629-632.
Impact Factor: 2.5
View Export to BibTeX Export to EndNote
Cucinotta V, Mangano A, Nobile G, Santoro AM, Vecchio G
New platinum(II) complexes of β-cyclodextrin diamine derivatives and their antitumor activity (468 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 1993 Nov 15; 52(3): 183-190.
Impact Factor: 1.342
View Export to BibTeX Export to EndNote
Di Blasio B, Pavone V, Nastri F, Isernia C, Saviano M, Pedone C, Cucinotta V, Impellizzeri G, Rizzarelli E, Vecchio G
Conformation for a β-cyclodextrin monosubstituted with a cyclic dipeptide (500 views)
P Natl Acad Sci Usa (ISSN: 0027-8424, 1091-6490, 0027-8424print), 1992 Sep 1; 89(15): 7218-7221.
Impact Factor: 9.04
View Export to BibTeX Export to EndNote
Rossi F, Zaccaro L, Di Blasio B, Pavone V, Maglio O, Saviano M, Pedone C, Cucinotta V, Impellizzeri G, Rizzarelli E, Vecchio G
beta-Cyclodextrins as potent bioactive delivery system (435 views)
Peptides, 1992; N/D: 577-578.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Cucinotta V, D'Alessandro F, Impellizzeri G, Pappalardo G, Rizzarelli E, Vecchio G
Cyclopeptide Functionalized beta-Cyclodextrin. A New Class of Potentially Enzyme Mimicking Compound with Two Recognition Sites (268 views)
Chem Commun, 1991; N/D: 293-294.
Impact Factor: 0
View Export to BibTeX Export to EndNote
59 Records (57 excluding Abstracts).
Total impact factor: 230.695 (226.816 excluding Abstracts).
Total 5 year impact factor: 236.818 (230.365 excluding Abstracts).
Total impact factor: 230.695 (226.816 excluding Abstracts).
Total 5 year impact factor: 236.818 (230.365 excluding Abstracts).
618 views. Last view on Monday 15 May 2023, 9:59:53
ibb.cnr.it
